Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer-Reference-Cited by-同舟云学术

Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer

Published:2015-12 Issue:6 Volume:24 Page:769-773
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Janni Wolfgang,Sarosiek Tomasz,Karaszewska Boguslawa,Pikiel Joanna,Staroslawska Elzbieta,Potemski Piotr,Salat Christoph,Brain Etienne,Caglevic Christian,Briggs Kathryn,Mahood Kim,DeSilvio Michelle,Marini Luca,Papadimitriou Christos

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference20 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review;Dawood;J Clin Oncol,2010

3. Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer;Pegram;J Natl Cancer Inst,2004

4. Randomized study of lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer;Blackwell;J Clin Oncol,2010

5. A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses;Cameron;Breast Cancer Res Treat,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients;The Breast;2021-10

2. Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer;Cochrane Database of Systematic Reviews;2021-05-26

3. Vinca Alkaloids as Chemotherapeutic Agents Against Breast Cancer;Discovery and Development of Anti-Breast Cancer Agents from Natural Products;2021

4. SNORA71B promotes breast cancer cells across blood–brain barrier by inducing epithelial-mesenchymal transition;Breast Cancer;2020-05-23

5. Efficacy and safety of lapatinib in Chinese breast cancer patients: a real-world study;Annals of Translational Medicine;2020-03